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S U M M A R Y
Culture-negative endocarditis is most often the result of prior antimicrobial therapy. Tropheryma
whipplei is the etiologic agent of Whipple’s disease, which is typically characterized by diarrhea, weight
loss, and intra-abdominal lymphadenopathy. We present the case of a 48-year-old male with Whipple’s
endocarditis of the aortic valve who did not develop signs of systemic Whipple’s disease. Our patient was
treated with a regimen that included ceftriaxone for 6 weeks prior to his cardiac surgery, yet valve
pathology demonstrated abundant T. whipplei, suggesting that a prolonged antibiotic course is necessary
for the treatment of Whipple’s endocarditis.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Culture-negative endocarditis is most often the result of prior
antimicrobial therapy.1 Tropheryma whipplei is the etiologic agent of
Whipple’s disease, which is typically characterized by diarrhea,
weight loss, intra-abdominal lymphadenopathy, and migratory
polyarthritis or polyarthralgia in men.2,3 Whipple’s endocarditis is
rare. We present the case of a 48-year-old male with culture-
negative endocarditis of the aortic valve. Pathology and molecular
tests subsequently conﬁrmed T. whipplei to be the cause of the
patient’s endocarditis.
2. Case report
A 48-year-old previously healthy man presented to hospital
with cognitive impairment, dysarthria, and left-sided paralysis.
Computed tomography (CT) scanning of his head conﬁrmed a
large right middle cerebral artery infarct. He was treated with
intravenous heparin, cholesterol lowering medication, and anti-
platelet therapy. At the time of admission, he had a diastolic heart
murmur. Echocardiography conﬁrmed severe aortic insufﬁciency
with a vegetation involving the right coronary cusp. Blood
cultures were negative and he was started on intravenous* Corresponding author. Tel.: +1 613 761 4220; fax: +1 613 761 4712.
E-mail address: tmesana@ottawaheart.ca (T.G. Mesana).
1201-9712/$36.00 – see front matter  2011 International Society for Infectious Disea
doi:10.1016/j.ijid.2011.05.020vancomycin and ceftriaxone. The patient was clinically stable,
and given his cognitive impairment, he was not taken for
immediate surgery. He was referred for surgery after a 6-week
course of parenteral antibiotics due to congestive heart failure
that was refractory to medical therapy. He underwent uneventful
aortic valve replacement with a 23-mm Carpentier–Edwards
Perimount bioprosthesis, and closure of a patent foramen ovale.
His native aortic valve cusps showed marked destruction, and
macrophages contained periodic acid–Schiff (PAS) stain-positive
material (Figure 1). Silver stain demonstrated numerous bacillary
structures. The valve was submitted to the National Microbiology
Laboratory of the Public Health Agency of Canada (Winnipeg,
Manitoba) for further testing. T. whipplei was identiﬁed in the
aortic valve tissue using an in-house speciﬁc PCR assay.
Ceftriaxone was restarted, and trimethoprim–sulfamethoxazole
(TMP–SMX) was added. Given these pathologic ﬁndings, cere-
brospinal ﬂuid (CSF) analysis was subsequently recommended,
but was not performed as the patient repeatedly refused to
undergo a lumbar puncture. Furthermore, the patient displayed
marked clinical improvement on therapy, brain magnetic
resonance imaging (MRI) revealed no enhancing or mass lesions,
and it was felt that his therapy would not likely be impacted by
CSF ﬁndings. After 6 weeks post-operatively, the patient
remained asymptomatic and ceftriaxone was discontinued. He
remains on TMP–SMX and has not developed any new symptoms
characteristic of Whipple’s disease 14 months following his
surgery.ses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Aortic valve immunohistochemistry for Whipple endocarditis: (A) periodic acid–Schiff stain-positive macrophages; (B) Grocott silver stain showing thin bacilli; (C)
and (D) acute inﬂammation with cusp destruction and macrophage accumulation.
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Whipple’s disease is caused by T. whipplei,2 an intracellular
organism that typically infects macrophages of the intestinal
mucosa.2 T. whipplei possesses deﬁciencies in energy metabolism
and amino acids synthesis, which makes laboratory diagnosis via
culture difﬁcult.3
The incidence of Whipple’s disease is unknown, but is
estimated to be less than 1 case per 1 million people per year.3
Patients with Whipple’s disease commonly present with gastroin-
testinal symptoms, and occasionally with neurologic and muscu-
loskeletal complaints.1 In patients with Whipple’s disease,
neurologic signs commonly include confusion and decreased level
of consciousness.3 Less than 10% of patients display hemiparesis or
ataxia.3 Brain imaging typically reveals either enhancing or mass
lesions on CT or MRI.3 Whipple’s endocarditis is uncommon, and
may involve both native and prosthetic heart valves;2 to date, just
over 100 cases have been described in the literature.4 In patients
with native valve endocarditis, T. whipplei most often involves the
aortic valve.2 Whipple’s endocarditis has rarely been reported to
occur in patients without systemic Whipple’s disease.
The diagnosis of Whipple’s endocarditis involves a combination
of pathology and PCR analysis from surgically obtained cardiac
valves.2 T. whipplei-infected macrophages stain positive on PAS stain
(Figure 1A). Silver stain shows thin bacilli (Figure 1B). Laboratory
diagnosis of T. whipplei is often made by PCR using broad-range
primers for ampliﬁcation of the 16S ribosomal ribonucleic acid
(rRNA) gene or the intergenic region of the 16S–23S rRNA gene,
followed by sequencing of the ampliﬁed product.3Misidentiﬁcation
is possible due to contamination of sample or PCR reagents with
unrelated bacterial DNA, or lack of sequence divergence betweenspecies. Therefore, a combination of PAS stain, PCR conﬁrmation
with sequencing, and/or immunohistochemistry using antibody
speciﬁc against T. whipplei should be used.3
Treatment of Whipple’s endocarditis involves both surgical and
medical (antimicrobial) therapy. Valve replacement with either a
bioprosthesis or mechanical prosthesis has been described.2,3 T.
whipplei is susceptible in vitro to doxycycline, sulfamethoxazole,
penicillin, third-generation cephalosporins, carbapenems, amino-
glycosides, and chloramphenicol.3 Treatment of Whipple’s disease
should include agents that cross the blood–brain barrier, since
relapses of disease usually present with neurologic manifesta-
tions.2 The current recommended treatment includes a 2-week
course of parenteral ceftriaxone followed by long-term TMP–
SMX.3 Our patient was treated with a regimen that included
ceftriaxone for 6 weeks prior to his cardiac surgery, yet valve
pathology demonstrated abundant T. whipplei, suggesting that a 2-
week course of ceftriaxone may be insufﬁcient in some cases.
Antibiotic therapy should be continued long-term for 12–18
months,3 similar to the treatment of Q-fever endocarditis in which
relapse has been described with short-term antibiotic therapy.5
Relapses of Whipple’s disease have been reported in up to one third
of cases, depending on the treatment regimen.3
In summary, there have been few published reports of Whipple’s
endocarditis in the absence of Whipple’s disease. Although rare, this
case emphasizes the importance of pathology, histochemistry, and
molecular analysis in identifying important causes of culture-
negative endocarditis. Accurate identiﬁcation of T. whipplei and
other unculturable pathogens can signiﬁcantly impact the manage-
ment of patients with culture-negative endocarditis.
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